Rich Trimble is a Senior Associate at ShangBay Capital where he is responsible for deal sourcing, due diligence, and screening target investments.

 

Previously, he worked at Sangmo Therapeutics in the R&D division and was a research assistant at the Energy Biosciences Institute at UC Berkeley. He was also a lecturer at UC Berkeley's School of Public Health. 

 

Rich holds an MD from Stanford University School of Medicine and M.S. in Epidemiology and Clinical Research from Stanford. He holds a B.S. from UC Berkeley in Molecular Toxicology.